Showing results (1751-1760 of 2,265) with videos related to

Sort By:
Pageof 227
Clinical Genetics|July 4, 2015
Whole-exome sequencing improves the diagnosis yield in sporadic infantile spasm syndromeS Dimassi, A Labalme, D Ville, et al.
British Journal of Haematology|September 30, 2021
Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B-cell lymphomaMax S Topp, Tom van Meerten, Roch Houot, et al.
Leukemia|April 26, 2016
CD49d prevails over the novel recurrent mutations as independent prognosticator of overall survival in chronic lymphocytic leukemiaM Dal Bo, P Bulian, R Bomben, et al.
Nature Medicine|August 29, 2022
Tumor immune contexture is a determinant of anti-CD19 CAR T cell efficacy in large B cell lymphomaNathalie Scholler, Regis Perbost, Frederick L Locke, et al.
Science (New York, N.Y.)|April 16, 2021
Parity-preserving and magnetic field-resilient superconductivity in InSb nanowires with Sn shellsM Pendharkar, B Zhang, H Wu, et al.
Blood Cancer Journal|November 11, 2014
Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specifiedM A Laginestra, P P Piccaluga, F Fuligni, et al.
Updates in Surgery|June 1, 2026
The Italian landscape of robotic-assisted kidney transplantation: results from a national surveyC Guidetti, S Serni, U Boggi, et al.
Molecular Cancer Therapeutics|December 5, 2023
ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid NeoplasmsAlberto J Arribas, Sara Napoli, Luciano Cascione, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 24, 2015
Improved survival in liver transplant recipients receiving prolonged-release tacrolimus in the European Liver Transplant RegistryR Adam, V Karam, V Delvart, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
ERBB4-mediated signaling is a mediator of resistance to BTK and PI3K inhibitors in B cell lymphoid neoplasmsAlberto J Arribas, Sara Napoli, Luciano Cascione, et al.
Pageof 227